Clearside Biomedical, Inc. (CLSD)

Clearside Biomedical Revenue

Clearside Biomedical had revenue of $2.21M in the twelve months ending September 30, 2023, down -91.71% year-over-year. Revenue in the quarter ending September 30, 2023 was $859.00K with 222.93% year-over-year growth. In the year 2022, Clearside Biomedical had annual revenue of $1.33M, a decrease of -95.51%.

• Revenue (ttm): $2.21M
• Revenue Growth: -91.71%
• P/S Ratio: 28.51
• Revenue / Employee: $61,417
• Employees: 36
• Market Cap: 63.03M USD

Revenue History

Fiscal Year End	Revenue	Change	Growth
Dec 31, 2022	1.33M	-28.25M	-95.51%
Dec 31, 2021	29.58M	21.68M	274.65%
Dec 31, 2020	7.89M	5.72M	263.28%
Dec 31, 2019	2.17M	2.14M	7,143.33%
Dec 31, 2018	30.00K	-315.00K	-91.30%
Dec 31, 2017	345.00K	-175.00K	-33.65%
Dec 31, 2016	520.00K	-	-
Dec 31, 2015	0	-	-
Dec 31, 2014	0	-	-

Sources: Historical revenue is based on company filings submitted to the U.S. Securities and Exchange Commission (SEC). The most recent revenue numbers may be taken from company press releases.